Milltrust Investment Attomarker featured on BBC Spotlight

November 10, 2021

BY Milltrust International Group

BBC Spotlight interview Professor Andrew Shaw, Founder & CEO of Attomarker, a company backed by Milltrust, and Robert W. Badcock, CEO Mantracourt Electronics on their collaboration of the world’s first rapid point-of-care quantitative test revealing whether your antibody levels are above or below a threshold of protection.

Contact us for more information on Attomarker’s current Acceleration funding round. 

Attomarker featured on BBC Spotlight

Categories: News